Acute kidney injury (AKI) is hard.
Things that seem like they should work often don’t. Just ask Perry Wilson.
And even the most predictable cases of AKI are resistant to intervention. Look at bypass surgery. We know days in advance the time and place the AKI will occur and despite that foreknowledge, like Cassandra, we are powerless to prevent the AKI. Same with contrast administration (or not). Same with AAA surgery. We have been unable to meaningfully reduce the rate of AKI in any clinical circumstance.
AKI is a tough nut to crack.
So when I read about this guy, Mustafa Suleyman (Twitter), telling the public that,
“There are around 1,000 people a month dying needlessly. This is a huge hidden killer. It costs more than breast cancer care in the UK and [AKI] is super simple to prevent.”
I’m insulted, like we must be idiots that we haven’t fixed this yet. And thank-god the computer scientists are here from Google to finally cure AKI for us.
Turns out the National Health Service is implementing a system at The Royal free Hospital to speed alerts to doctors so they can react quickly to signals of acute kidney injury. The headlines being generated from this project are amazing:
The company providing artificial intelligence is DeepMind, a Google company. The product that detects AKI early enough to avoid it is Streams.
Maybe we should excuse the visionary of an artificial intelligence company. The medical director of the Royal Free should be a bit less grandiose and more evidence based. What did he have to say?
Stephen Powis, medical director at the Royal Free said, “We know that a quarter of deaths from acute kidney injury are preventable if clinicians are able to intervene earlier and more effectively.”
Boy, that sounds like data that comes from an interventional trial where warnings were given to some clinicians, and others did not receive them, and the RR for AKI was 0.75. Unfortunately, this study has never been done. When a similar study was done by Perry Wilson they found no effect at all from early warnings. When I asked Twitter if they knew where this data came from I was given a few old retrospective trials.
? data from NCEPOD AKI report in the UK
— Declan de Freitas (@ddfirl) November 22, 2016
Nothing prospective. Nothing to justify the certainty of Dr. Powis. The 25 percent comes from a report produced by NCEPOD called Adding Insult to Injury. The report attempted to analyze all of the deaths for three months in 2007 due to AKI. They failed to capture surgical patients, and they did not get the records on 40 percent of the cases they requested.
As part of this examination of the failures, they asked experts that reviewed the case files if the AKI was avoidable and they said yes it was in 14 percent of the cases. I’m sorry, but the distance between a reviewer believing an episode is avoidable and an AKI case actually being avoidable is more than a casual step, let’s call it a major leap. Remember that reviewers were only reviewing patients with mortal outcomes. Given that, the reviewers knew of the subpar outcome, I’m not surprised the reviewers found lots of substandard care:
Maybe I am jumping the gun and the Deep Mind notification system, Streams has been prospectively vetted and shown to improve outcomes. I also concede that it is likely that the system can improve the number of AKIs but that isn’t and shouldn’t be the sole goal of the system. AKI is an intermediate outcome. The system should be judged on its ability to reduce mortality, and here I am skeptical. I suspect the AKIs that are simple to avoid are not the ones driving the high mortality levels.
I believe the Deep Mind people have this type of model of AKI:
In this model, all the different etiologies of AKI feed into a single pool of undifferentiated AKI and measures that reduce the incidence of any of the causes of AKI will reduce the fraction of patients that die of AKI.
I think the correct model of AKI is more like this:
In this model each etiology of AKI leads to mortality in it’s own lane. So changes in the incidence of AKI from volume depletion can only reduce the already low mortality from that cause of AKI.
I look forward to seeing the results of this project and hope that they are measuring the outcomes and plan to publish their prospective and interventional data.
Joel Topf is a nephrologist who blogs at Precious Bodily Fluids.
Image credit: Shutterstock.com